Contract & Compliance Counsel – Construction & Energy (Global)
Enregistrez cette offre et organisez votre recherche
Créez un compte gratuit pour enregistrer des offres d'emploi, créer des alertes et revenir à cette liste depuis votre tableau de bord.
En continuant, vous acceptez nos Conditions d’utilisation & Politique de confidentialité.
Denys NV in Gent (Wondelgem) is seeking a Legal Counsel to work closely with the business on complex construction, infrastructure and energy projects across Europe. You will combine contract law, public procurement, risk management and pragmatic legal advice in an international project environment.
You will become part of the Legal department to support activities in Belgium and throughout Europe, reviewing contracts, drafting documents and negotiating with clients and subcontractors.
-
Contract & Compliance Counsel – Construction & Energy (Global)
Il y a 5 heures
Gent, Vlaanderen, Belgique Denys Temps pleinDenys NV in Gent (Wondelgem) is seeking a Legal Counsel to work closely with the business on complex construction, infrastructure and energy projects across Europe. You will combine contract law, public procurement, risk management and pragmatic legal advice in an international project environment.You will become part of the Legal department to support...
-
Legal Counsel, Clinical Development
Il y a 2 jours
Gent, Belgique argenx Télétravail Temps pleinJoin us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...
-
DT AI Platform Lead
Il y a 2 jours
Gent, Belgique argenx Temps plein 152 000 € - 209 000 € ContratJoin us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...